Overcoming beta-lactam resistance in Pseudomonas aeruginosa by targeting metallo-beta-lactamase VIM-1: a one-microsecond molecular dynamics simulation study
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1521391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Mohammed Salleh M Ardawi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathological Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, beta-Lactamases, beta-Lactam Resistance, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen with a high resistance to beta-lactam antibiotics, mainly due to the production of metallo-beta-lactamase VIM-1 (MBL-VIM-1) enzyme. This study aimed to identify new inhibitors targeting MBL-VIM-1 to restore the efficacy of beta-lactam antibiotics. Extensive screening of natural compounds from the COCONUT database was performed to identify the structural analogs of the existing inhibitor of the MBL-VIM-1 protein. The virtual screening process selected four top-performing compounds (CNP0390322, CNP03905695, CNP0079056, and CNP0338283) that exhibited promising docking scores. These compounds were then subjected to re-docking and one-microsecond molecular dynamics (MD) simulations to assess their binding stability and interactions within the MBL-VIM-1 active site. Finally, post-MD simulation calculations were employed to estimate the interaction strengths and compare the efficacy of these compounds against the reference inhibitor. The findings highlighted that these four potent MBL-VIM-1 inhibitors show superior binding affinity and stability, suggesting their potential to combat antibiotic resistance in P. aeruginosa . The identified compounds offer a promising avenue for developing novel therapeutics to restore the efficacy of beta-lactam antibiotics against resistant bacterial strains. Therefore, further in vitro and in vivo studies are warranted to validate their potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathological Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
- Infection Control Department, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
- Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Science, Taibah University, Medina, Saudi Arabia.
- Medical Laboratory Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Zitieren
APA
Ardawi, M. S. M., Badreddine, S. A., Yasir, M., Khateb, A. M., Turkistani, S. A., Afandi, A., Noor, S. O., Alselmi, A., Dwivedi, V. D., & Azhar, E. I. (2025). Overcoming beta-lactam resistance in Pseudomonas aeruginosa by targeting metallo-beta-lactamase VIM-1: a one-microsecond molecular dynamics simulation study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1521391
Vancouver
Ardawi MSM, Badreddine SA, Yasir M, Khateb AM, Turkistani SA, Afandi A, et al. Overcoming beta-lactam resistance in Pseudomonas aeruginosa by targeting metallo-beta-lactamase VIM-1: a one-microsecond molecular dynamics simulation study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1521391
BibTeX
@article{Ardawi2025,
author = {Ardawi, Mohammed Salleh M and Badreddine, Samar A and Yasir, Muhammad and Khateb, Aiah M and Turkistani, Safaa A and Afandi, Ahmed and Noor, Samah O and Alselmi, Adhari and Dwivedi, Vivek Dhar and Azhar, Esam I},
title = {Overcoming beta-lactam resistance in Pseudomonas aeruginosa by targeting metallo-beta-lactamase VIM-1: a one-microsecond molecular dynamics simulation study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1521391}
}
EUVIMED